| Fund ID | 805-8591061248 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 5% |
| Owned by funds of funds | 13% |
| Owned by non-U.S. persons | 17% |
| Fund | Type | Gross assets |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | Hedge | $1.25B |
| Frazier Life Sciences X, L.P. | Private Equity | $623.3M |
| Frazier Life Sciences XI, L.P. | Venture Capital | $549.2M |
Frazier Life Sciences VIII, L.P. reports $169.4 million in gross assets, among the top 33% of private funds by size.
The stated minimum investment is $3 million.
Frazier Life Sciences VIII, L.P. is managed by Frazier Life Sciences Management, LP.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.